As part of the agreement, a precision cancer research and treatment institute will be created at the Windber facilities.
BioServe touts the repository as the "the largest resource of high-quality biosamples for the life science industry" and claims that researchers can access it to garner biosamples from "most any major diseases."
The firm has started the BioServe Network with partners including Fox Chase, Windber, UMass, and the Fairbanks Institute for Healthy Communities.
BioServe will supplement its clinical-grade biospecimens in its Global BioRepository with biosamples from the Windber Research Institute's Tissue Bank.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.